|
1
|
Almangush A, Heikkinen I, Makitie AA,
Coletta RD, Laara E, Leivo I and Salo T: Prognostic biomarkers for
oral tongue squamous cell carcinoma: A systematic review and
meta-analysis. Br J Cancer. 117:856–866. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pfister DG, Ang KK, Brizel DM, Burtness
BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele
DW, et al: Head and neck cancers, version 2.2013. Featured updates
to the NCCN guidelines. J Natl Compr Canc Netw. 11:917–923. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gore SM, Crombie AK, Batstone MD and Clark
JR: Concurrent chemoradiotherapy compared with surgery and adjuvant
radiotherapy for oral cavity squamous cell carcinoma. Head Neck.
37:518–523. 2015. View Article : Google Scholar
|
|
5
|
Iyer NG, Tan DS, Tan VK, Wang W, Hwang J,
Tan NC, Sivanandan R, Tan HK, Lim WT, Ang MK, et al: Randomized
trial comparing surgery and adjuvant radiotherapy versus concurrent
chemoradiotherapy in patients with advanced, nonmetastatic squamous
cell carcinoma of the head and neck: 10-year update and subset
analysis. Cancer. 121:1599–1607. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goel HL, Li J, Kogan S and Languino LR:
Integrins in prostate cancer progression. Endocr Relat Cancer.
15:657–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Juan-Rivera MC and Martinez-Ferrer M:
Integrin inhibitors in prostate cancer. Cancers (Basel).
10:E442018. View Article : Google Scholar
|
|
8
|
Tan LZ, Song Y, Nelson J, Yu YP and Luo
JH: Integrin alpha7 binds tissue inhibitor of metalloproteinase 3
to suppress growth of prostate cancer cells. Am J Pathol.
183:831–840. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhandari A, Xia E, Zhou Y, Guan Y, Xiang
J, Kong L, Wang Y, Yang F, Wang O and Zhang X: ITGA7 functions as a
tumor suppressor and regulates migration and invasion in breast
cancer. Cancer Manag Res. 10:969–976. 2018. View Article : Google Scholar :
|
|
10
|
Ren B, Yu YP, Tseng GC, Wu C, Chen K, Rao
UN, Nelson J, Michalopoulos GK and Luo JH: Analysis of integrin
alpha7 mutations in prostate cancer, liver cancer, glioblastoma
multiforme, and leiomyosarcoma. J Natl Cancer Inst. 99:868–880.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ming XY, Fu L, Zhang LY, Qin YR, Cao TT,
Chan KW, Ma S, Xie D and Guan XY: Integrin a7 is a functional
cancer stem cell surface marker in oesophageal squamous cell
carcinoma. Nat Commun. 7:135682016. View Article : Google Scholar
|
|
12
|
Haas TL, Sciuto MR, Brunetto L, Valvo C,
Signore M, Fiori ME, di Martino S, Giannetti S, Morgante L, Boe A,
et al: Integrin a7 is a functional marker and potential therapeutic
target in glioblastoma. Cell Stem Cell. 21:35–50.e39. 2017.
View Article : Google Scholar
|
|
13
|
Carrasco-Garcia E, Auzmendi-Iriarte J and
Matheu A: Integrin a7: A novel promising target in glioblastoma
stem cells. Stem Cell Investig. 5:22018. View Article : Google Scholar
|
|
14
|
Abd El hafez A and El-Hadaad HA:
Immunohistochemical expression and prognostic relevance of Bmi-1, a
stem cell factor, in epithelial ovarian cancer. Ann Diagn Pathol.
18:58–62. 2014. View Article : Google Scholar
|
|
15
|
Hu Y and Smyth GK: ELDA: Extreme limiting
dilution analysis for comparing depleted and enriched populations
in stem cell and other assays. J Immunol Methods. 347:70–78. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Hynes RO: Integrins: Bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsu YL, Hung JY, Liang YY, Lin YS, Tsai
MJ, Chou SH, Lu CY and Kuo PL: S100P interacts with integrin a7 and
increases cancer cell migration and invasion in lung cancer.
Oncotarget. 6:29585–29598. 2015. View Article : Google Scholar : PubMed/NCBI
|
